-
admin
Posts
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief...
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical...
Nova Medical & Day Spa Opens Its Doors in Barrington, IL, Offering Premier Aesthetic Treatments
Barrington, IL, Dec. 30, 2024 (GLOBE NEWSWIRE) — Nova Medical & Day Spa is thrilled to announce its grand opening in the heart of Barrington, Illinois....
Ambow Education Announces Second Quarter and First Half of 2024 Financial Results
CUPERTINO, Calif., Dec. 31, 2024 /PRNewswire/ — Ambow Education Holding Ltd. (“Ambow” or the “Company”) (NYSE American: AMBO), a leading AI-driven educational and collaboration technology...
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce...
I Peace manufactures 100 lines of GMP iPS Cells cumulatively
Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., Dec. 31, 2024 /PRNewswire/ — Leading GMP cell CDMO I Peace, Inc....
Watch the Official Delta Force “Serpentine” PvE Raid Trailer
LOS ANGELES, Dec. 31, 2024 /PRNewswire/ — Prepare for an all-new type of Delta Force challenge. Operation Serpentine drops you and your squad behind enemy...
Dataloy Caps Off 2024 with Record Growth and Q4 Innovations Driving Maritime Excellence
Closing 2024 with close to 25% revenue growth, including a strong fourth quarter, Dataloy Systems continues to strengthen its position in maritime digitalisation. BERGEN, Norway,...
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of...
European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
This multitargeted, chemotherapy-free combination demonstrated superiority over osimertinib monotherapy for the first-line treatment of patients with EGFR-mutated NSCLC1 In the Phase 3 MARIPOSA study, amivantamab...
